| ProteoSys AG, a corporation of Germany Patent applications |
| Patent application number | Title | Published |
|---|
| 20100267051 | ANNEXIN FOR CANCER RISK ASSESSMENT - A method treats urogenital and/or intestinal tract cancer and includes administering a therapeutically effective amount of at least one annexion protein, annexin of A3, to a mammal. | 10-21-2010 |
| 20080200385 | Annexin for Cancer Risk Assessment - A method treats urogenital and/or intestinal tract cancer and includes administering a therapeutically effective amount of at least one annexion protein, annexin of A3, to a mammal. | 08-21-2008 |
